You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Citalopram hydrobromide - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for citalopram hydrobromide and what is the scope of patent protection?

Citalopram hydrobromide is the generic ingredient in two branded drugs marketed by Almatica, Mylan Pharms Inc, Forest Labs, Aurobindo Pharma, Chartwell Molecular, Hetero Labs Ltd Iii, Hikma, Pharm Assoc, Biovail Labs Intl, Abbvie, Amneal Pharms Ny, Apotex, Aurobindo, Cosette, Dr Reddys Labs Ltd, Epic Pharma, Epic Pharma Llc, Fosun Pharma, Glenmark Generics, Heritage Pharma, Invagen Pharms, Jubilant Generics, Mylan, Natco Pharma Ltd, Roxane, Sun Pharm Inds Inc, Sun Pharm Industries, Taro, and Torrent Pharms, and is included in thirty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-eight drug master file entries for citalopram hydrobromide. Forty-four suppliers are listed for this compound.

Drug Prices for citalopram hydrobromide

See drug prices for citalopram hydrobromide

Drug Sales Revenue Trends for citalopram hydrobromide

See drug sales revenues for citalopram hydrobromide

Recent Clinical Trials for citalopram hydrobromide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Otsuka Pharmaceutical Development & Commercialization, Inc.Phase 3
Alphacait, LLCPhase 2
Haining Health-Coming Biotech Co., Ltd.Phase 2

See all citalopram hydrobromide clinical trials

Pharmacology for citalopram hydrobromide
Medical Subject Heading (MeSH) Categories for citalopram hydrobromide

US Patents and Regulatory Information for citalopram hydrobromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hetero Labs Ltd Iii CITALOPRAM HYDROBROMIDE citalopram hydrobromide SOLUTION;ORAL 201450-001 Dec 15, 2015 AA RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Epic Pharma Llc CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 077036-001 Oct 28, 2004 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Jubilant Generics CITALOPRAM HYDROBROMIDE citalopram hydrobromide TABLET;ORAL 205407-001 Dec 23, 2015 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.